Submit Deal

NANYANG BIOLOGICS PTE LTD

HQ - Singapore

Summary

Nanyang Biologics (NYB) is an AI-driven drug discovery and biotechnology company accelerating the future of medicine through the convergence of artificial intelligence and natural compounds.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 1.11 B

Avg. Deal Size£ 1.11 B

Market Context

Senior Management

Roland Ong
Chairman

Sort

02 Oct 2025|Singapore|Biotechnology

Target: NANYANG BIOLOGICS PTE LTD

Bidder: RF ACQUISITION CORP II

3 Service Providers

1 Target | 1 Bidder | 1 Vendor

8 Dealmakers

1 Target | 6 Bidder | 1 Vendor

£ 1.11 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy